Norviburtinal is primarily used in the pharmaceutical industry as an intermediate in the synthesis of analgesic and anti-inflammatory agents. It plays a role in developing compounds that modulate pain pathways, making it valuable in research for non-opioid pain relief solutions. Due to its structural properties, it is also explored in the design of central nervous system (CNS) active drugs, particularly those targeting neuropathic pain and mood-related disorders. Its application extends to preclinical studies where it helps evaluate efficacy and safety profiles of new therapeutic candidates.